Journal of Clinical Medicine (Jun 2023)

Adipokines as Predictive Biomarkers for Training Adaptation in Subjects with Multimorbidity—A Hypothesis-Generating Study

  • Felipe Mattioni Maturana,
  • Rebecca Rolf,
  • Simone Schweda,
  • Max Reimer,
  • Manuel Widmann,
  • Christof Burgstahler,
  • Andreas M. Nieß,
  • Inga Krauss,
  • Barbara Munz

DOI
https://doi.org/10.3390/jcm12134376
Journal volume & issue
Vol. 12, no. 13
p. 4376

Abstract

Read online

Background. Physical exercise exerts a positive effect on many chronic conditions, specifically lifestyle-related diseases such as overweight and obesity, type 2 diabetes mellitus (T2DM), cardiovascular conditions and osteoarthritis (OA). As a result of common risk factors, most of these patients present with multiple conditions. Exercise- and disease-related biomarkers, such as adipokines, are emerging tools in training supervision and regulation; however, their significance in subjects with multimorbidities is unknown. Subjects and Methods. To address this issue, adipokines leptin, adiponectin and resistin were assessed in a cohort of subjects with multimorbidities (n = 39) presenting with at least two of the abovementioned conditions or relevant risk factors before and after a six-month exercise and lifestyle intervention program (‘MultiPill-Exercise’), and correlated with training adaptation, namely changes in relative maximum oxygen uptake (V·O2max). Results. There was a significant negative correlation between baseline leptin concentrations and training effect for relative V·O2max (after three months: rho = −0.54, p = 0.020 *; after six months: rho = −0.45, p = 0.013 *), with baseline leptin explaining 35% of the variance in delta relative V·O2max after three months and 23% after six months. Conclusions. Leptin might be a suitable surrogate biomarker in the context of exercise-based lifestyle intervention programs in subjects with multimorbidity.

Keywords